← All companies

STRO

Sutro Biopharma, Inc.

STRO Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$25.10

+0.28 +1.13%

Key statistics

from XBRL data in SEC filings

Market cap

$416M

Revenue (TTM)

$99.6M

Net income (TTM)

-$154M

EPS (TTM)

$-16.35

P/E ratio

—

Dividend yield

—

Free cash flow

-$179M

Cash

$73.7M

Total assets

$242M

Gross margin

—

52-week range

$7.15 – $43.85

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Terminated a material agreement; Results of operations (earnings release) Mar 23, 2026 8-K Entered a material agreement; Regulation FD disclosure Feb 10, 2026 8-K Other events Dec 17, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Exit or disposal costs Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Delisting notice or listing-rule failure Jun 25, 2025 8-K Shareholder vote results Jun 10, 2025 8-K Director or officer change Jun 2, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change Mar 13, 2025 8-K Other events Dec 10, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Aug 12, 2024 8-K Shareholder vote results Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Entered a material agreement Apr 2, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 25, 2024 8-K Results of operations (earnings release) Mar 25, 2024 8-K Other events Feb 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 8, 2024 8-K Entered a material agreement Nov 27, 2023 8-K Director or officer change; Regulation FD disclosure Nov 21, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023